new warnings for patients taking Cylert (pemoline)
July 1999
You'll see new warnings for patients taking Cylert (pemoline).
Cylert is no longer recommended for initial therapy of attention deficit disorder (ADD)...due to the risk of liver toxicity.
Now Abbott recommends that patients sign a consent form before starting Cylert...and get liver function tests EVERY TWO WEEKS.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote